Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (1751)	4/28/1998 8:32:00 PM
From: Todd N	Read Replies (1) \| Respond to of 9523

>>-Average Rx: $15<< At $10 a pill that is an average of 1 1/2 pills per script. Is that what was reported? I can't believe Doctors would overwelmingly prescribe 1 pill! Just curious. Todd

To: BigKNY3 who wrote (1751)	4/28/1998 9:05:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Impotence Drug Buyers Choose Viagra APRIL 28, 16:38 EDT NEW YORK (AP) -- Six times as many men are now seeking impotence cures than when Pfizer Inc.'s pill, Viagra, went on the market, according to an industry report. The Pfizer Inc. drug Viagra has swept the impotence market. It gained 94.4 percent of the market for such treatments in its third week of sales, ended April 17, according to figures released this week by IMS America Inc., a private drug industry researcher. Beyond usurping the No. 1 spot in the impotence market, Viagra has dramatically expanded the number of men who buy drugs to treat impotence. The market researcher estimates that the market for sexual disorder treatments has jumped 511 percent since Viagra went up for sale. That includes men who are continuing prescriptions of earlier drugs. New prescriptions have risen even more quickly. There were only 11,549 men filling new prescriptions for impotence in the week ended April 3, according to IMS. Now there are 119,810. The drug picked up 5 percent of new prescriptions in its first week and a 79 percent by the second week, according to IMS figures. In the latest week, 113,134 of the 119,810 men who filled prescriptions for impotence treatments bought Viagra, known generically as sildenafil. That compares with 4,609 for Muse, a distant No. 2 seller with 3.8 percent of the market. Muse, a suppository that is inserted by a slender plunger pushed into the end of the penis. Muse, which had 69 percent of the market when Viagra came on the market, has suffered most from the new drug's debut. The first impotence drug approved by the Food and Drug Administration in 1995, Pharmacia & Upjohn's injected drug Caverject, accounted for 1,761 of new prescriptions filled in the latest week, or 1.5 percent of the market.

To: BigKNY3 who wrote (1751)	4/28/1998 10:29:00 PM
From: James Baker	Read Replies (2) \| Respond to of 9523

BigkNY: Revere:Here is a summary of today's Faber File Report that was shown today on CNBC (I tape the entire CNBC show): -An independent auditing firm NDC Health Information Services (not IMS) reported the following: -206,000 Viagra Rxs written last week (46,000 on Friday) -Average Rx: $15 -Run rate: : $20 million a week>>>>>>>>>>>>>>>> two questions BigK, 1. ever hear of NDC before - who's knows about their quality, reliability etc? 2. average RX $15 = 1.5 tablets???????????????? Jim